Categorization and impact of pulmonary hypertension in patients with advanced COPD.
about
Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management StrategiesPulmonary vasculature in COPD: The silent componentLung transplantation in chronic obstructive pulmonary disease: patient selection and special considerationsEnd-of-life prognostic indicators in patients with COPD: part 2.Right Atrium Volume Index in Patients with Secondary Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease.CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.Pulmonary hypertension and right heart dysfunction in chronic lung disease.Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPDThe safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary diseaseRight heart structural changes are independently associated with exercise capacity in non-severe COPDEpidemiology and clinical impact of major comorbidities in patients with COPD.Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungsAcute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary diseasePulmonary hemodynamic profile in chronic obstructive pulmonary disease.Functional and Prognostic Implications of the Main Pulmonary Artery Diameter to Aorta Diameter Ratio from Chest Computed Tomography in Korean COPD PatientsPulmonary Hypertension Secondary to COPD.Electrocardiographic differences between COPD patients evaluated for lung transplantation with and without pulmonary hypertension.The role of pulmonary arterial stiffness in COPD.Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP).Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD.A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertensionAcute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary diseasePulmonary hypertension associated with lung diseases and hypoxemia.Upregulation of SRF Is Associated With Hypoxic Pulmonary Hypertension by Promoting Viability of Smooth Muscle Cells via Increasing Expression of Bcl-2.Pulmonary hypertension as a risk factor of mortality after lung transplantation.The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia.Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population.Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.
P2860
Q26738405-67EDA980-C5A6-4A58-AC7B-7DD7F5223EC6Q26749309-8FDC210B-981B-44D1-B4AC-505DC0D5C052Q26778492-B0BDD522-E8AF-40E3-8F5E-0C7A6F494915Q30240694-C94D1951-4417-4472-9B51-F18B2976B37BQ30385148-1646A770-7140-4876-8B48-2A1349FAC292Q30415182-6BF4729E-317A-4EDD-B9D6-B3E634283276Q30432299-E430E75B-C2A6-48B7-9E4D-4E932BB3FF41Q33645372-97AD8AB3-71CD-4386-B873-9592100827C1Q33713681-85B7317A-03B7-436B-A4FB-420BD51AB1A6Q33738555-6271EB8E-8314-4A1E-B970-83A9437409C9Q33765096-2C0F3022-2107-4899-ADD5-415249B17534Q34119067-758DA22E-3615-452A-8493-338C96804342Q34134841-B5643E1E-55A4-44C0-BE8C-6866A583D35BQ34999736-795BB1BA-6FCD-4A8C-8484-A69EA22AF5CFQ35665739-7348914A-E897-46AF-87ED-34F3EF059052Q35866405-D12BCEAD-354A-44FD-9C1C-6189CD49523BQ36010823-ED52FFA5-961A-43A3-B8F0-9BAA7A9EAEFBQ36221051-594E5DB4-D58A-40DC-91F7-F0ED7A3F789DQ36253358-72F45FAB-A357-44B1-92A9-6E4D3B41D5A3Q36284886-6AA3B749-2D9A-4A32-93E7-A1CDA9643A23Q36676088-C7DF83D1-A7F0-4F90-B319-BB4B8249EF1DQ36752368-103956E8-8C21-474D-8822-4D682CCA0777Q37273505-5E3D49CA-E3BF-4DAE-936C-CE7F7ECEF781Q37311952-4AD6CBBD-502C-40F9-BCA1-D68B91F75EE9Q37644823-68B6272B-7ECE-4CC7-8038-9A90BEF17C30Q38023517-99BA2AE7-11DB-4084-9B82-FF5F7D9056EEQ38538687-1AC69E5F-C85C-4751-A7FD-6E36EB9A47FEQ38598994-77F2276A-C174-432A-9552-04B2BF4CE033Q38810145-E69D6695-35FB-48E4-ACF1-768DC292B10EQ38972873-D752C3C9-DB07-4A9E-99D1-1F98E84A3FE0Q40967652-40F03BD7-BC10-458B-A88E-F2CD5693B7E5Q41271986-76830DCE-99EB-498A-B945-8425C8EA3EBAQ41355520-B0D4DCEC-F705-4C7C-BFA5-0929121EF693Q41363891-D827E224-13E5-46C8-BFC9-9BED1C93FA2FQ41838314-A4DB7441-ECB9-49C3-BC5A-DF96D4D0C0F6Q45326440-7FAA3557-D1CE-4F17-B3C3-378179DA54AFQ47137930-C4F9C44F-E02E-4969-B213-817A0CEB35F5Q47423719-AB52B317-DA31-4B79-88AE-F42201D99C64Q47655340-4F54316F-1403-4529-87EC-EE247BDF1E76Q47896499-760827AC-FB8C-4F75-B8D5-2E1868E20254
P2860
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@en
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@nl
type
label
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@en
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@nl
prefLabel
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@en
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@nl
P2093
P921
P1433
P1476
Categorization and impact of pulmonary hypertension in patients with advanced COPD.
@en
P2093
Mark Gladwin
Michael J Cuttica
Oksana A Shlobin
Ravi Kalhan
Roberto F Machado
Scott D Barnett
Shahzad Ahmad
Steven D Nathan
P304
P356
10.1016/J.RMED.2010.05.009
P577
2010-06-14T00:00:00Z